ARTICLE | Company News
Celgene sales and marketing update
July 20, 2015 7:00 AM UTC
The German Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that added benefit cannot be derived for Otezla apremilast to treat moderate to severe plaque psori...